Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Original Research

Accepted on 09 Jul 2025

L1, a 3,3'-Diindolylmethane-derivative, induced ER stress-mediated apoptosis and suppressed growth through the FLI1/AKT pathway in erythroleukemia HEL cells

in Pharmacology of Anti-Cancer Drugs

Yi Kuang
Yong Jian
Dinghuan Wang
Lihao Bai
Kunlin Yu
WANG CHUNLIN
Wuling Liu
Sheng Liu
Wan Li
Yaacov Ben-David

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1564199

Systematic Review

Accepted on 09 Jul 2025

Efficacy and safety of different treatments in chemotherapy-induced thrombocytopenia: a systematic review and network meta-analysis

in Pharmacology of Anti-Cancer Drugs

Huiyan Yang
Xiaoxiao Xu
Mei Tan
Jingyu Gao
Ruihan Fang
Xuan Liu
Zhaokun Chen
Libai Chen
Yongsheng Ruan
Yiqi Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1549214

Original Research

Published on 09 Jul 2025

STAT3 mediates CAF-induced osimertinib resistance via regulating protein secretion in non-small cell lung cancer

in Pharmacology of Anti-Cancer Drugs

Xuchen Fan
Sheng Wu
Honglong Wu
Yingying Huang
Xuhui Tong
Meiling Yu
Zhe Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1546491

176 views

Review

Accepted on 08 Jul 2025

The role of ubiquitination and deubiquitination in urological tumours

in Pharmacology of Anti-Cancer Drugs

Lifeng Gan
Peiyue Luo
Junrong Zou
Wei Li
琪陈
乐程
Fangtao Zhang
Haidong Zhong
Liying Zheng
Biao Qian

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1532878

Original Research

Accepted on 08 Jul 2025

2H-1,4-Benzoxazin-3(4H)-one Linked 1,2,3-Triazole Derivatives and Their Study on Inducing DNA Damage in Tumor Cells

in Pharmacology of Anti-Cancer Drugs

Xixi Hou
Yajie Guo
Longfei Mao
En Gao
Jianxue Yang
Xi Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1564090

Systematic Review

Accepted on 08 Jul 2025

The Protective Role of Curcumin in Mitigating Drug-Induced Toxicity in Male Reproductive Systems

in Pharmacology of Anti-Cancer Drugs

Mitra Tarlan
Shabnam Moradi
Niloofar Heidarizade
Omid Tavallaei
Saeed Khazayel
Mohammad Hosein Farzaei
Javier Echeverria

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1620732

Original Research

Published on 08 Jul 2025

Dihydroartemisinin targets the miR-497-5p/SOX5 axis to suppress tumor progression in non-small cell lung cancer

in Pharmacology of Anti-Cancer Drugs

Qing-Hua Yin
Qiang Zhou
Jian-Bing Hu
Jie Weng
Er-Dong Shen
Fang Wen
Song-Lian Liu
Lei-Lan Yin
Ya-Jun Tong
Ling Long

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1605531

378 views

Review

Published on 08 Jul 2025

Unlocking the potential of antibody-drug conjugates in cervical cancer: emerging targets and clinical trials

in Pharmacology of Anti-Cancer Drugs

Yue Zhang
Yao Ding
Yiran Liao
Jin Shu
Yi Gong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1636120

365 views

Review

Published on 08 Jul 2025

CRISPR/Cas9 technology in tumor research and drug development application progress and future prospects

in Pharmacology of Anti-Cancer Drugs

Han Han
Xiaoyan Sun
Xiaoyun Guo
Jiaxin Wen
Xiaoming Zhao
Weiqiang Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1552741

516 views

Original Research

Published on 08 Jul 2025

Independent risk and protective factors for oxaliplatin-induced hypersensitivity reactions: a retrospective study

in Pharmacology of Anti-Cancer Drugs

Jing Xue
Zhihao Lian
Xiaoyan Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1624322

221 views

Original Research

Published on 08 Jul 2025

Prevention of chemotherapy drug-mediated human hair follicle damage: combined use of cooling with antioxidant suppresses oxidative stress and prevents matrix keratinocyte cytotoxicity

in Pharmacology of Anti-Cancer Drugs

Khalidah Ibraheem
Adrian Smith
Andrew Collett
Nikolaos T. Georgopoulos

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1558593

572 views

Mini Review

Published on 08 Jul 2025

Advancements in bladder cancer immunotherapy: a focus on intravesical approaches

in Pharmacology of Anti-Cancer Drugs

Xia Tang
Tianlun Yu
Hongxuan Tong
Yufan Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1578146

201 views

Review

Accepted on 07 Jul 2025

Melatonin: A Natural Guardian in Cancer Treatment

in Pharmacology of Anti-Cancer Drugs

Yurou Cao
Hang Zhang
Xubin Chen
Conghui Li
Jingxin Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1617508

Systematic Review

Accepted on 07 Jul 2025

The efficacy and safety of cabazitaxel in the treatment of metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis based on randomized controlled trials

in Pharmacology of Anti-Cancer Drugs

Cong Shao
Quan Wan
Jia Guo
Zhuo Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1586650

Review

Accepted on 07 Jul 2025

Progress of Targeted FOX Family Therapy in Ovarian Cancer

in Pharmacology of Anti-Cancer Drugs

Hairong Zhang
Cuiping Gong
Xin Lv

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1604998

Original Research

Accepted on 07 Jul 2025

Fenbendazole Induces Pyroptosis in Breast Cancer Cells through HK2/Caspase-3/GSDME Signaling Pathway

in Pharmacology of Anti-Cancer Drugs

Tingting Pan
Shengqi Jin
Xiaoxia Huang
Xin Xin
Qiming Xing
Wenhui Yang
Jing Dong
Lin Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1596694